Clinical Trials Sponsored by Intogrey Research and Development Inc.

Total 4869 results

University of Alberta
Canadian Institutes of Health Research (CIHR); Alberta Health services; Cambian... and other collaborators

Completed

Electronic Patient-Reported Outcomes in Clinical Kidney Practice (ePRO Kidney)

Kidney Disease, End-Stage

Canada
National Development and Research Institutes, Inc.

Unknown

Mobile Intervention for Young Opioid Users

Opioid-Related Disorders

United States
National Development and Research Institutes, Inc.

Unknown

Applying Web Technology to Buprenorphine Treatment

Adult Opioid-Dependence

United States
National Development and Research Institutes, Inc.

Unknown

The Staying Safe Intervention (Ssafe)

Hepatitis C | Opioid Use

United States
National Development and Research Institutes, Inc.

Unknown

Increasing HIV Testing in Urban Emergency Departments Via Mobile Technology

HIV Testing

United States
Finch Research and Development LLC.
Medpace, Inc.

Completed

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection (PRISM-EXT)

Clostridium Difficile Infection | Recurrent Clostridium Difficile Infection | C. Diff | CDI | Recurrent C. Diff | rCDI | C. Difficile | Recurrent CDI | FMT | Fecal Microbiota | Fecal Transplant

United States, Canada
Centocor Research & Development, Inc.

Completed

A Study of Safety and Effectiveness of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Plaque-type Psoriasis (PHOENIX1)

Psoriasis

United States, Belgium, Canada
Centocor Research & Development, Inc.

Completed

A Study of the Safety and Efficacy of Single-agent Carlumab (an Anti-Chemokine Ligand 2 [CCL2]) in Participants With Metastatic Castrate-Resistant Prostate Cancer

Prostate Cancer

United States, United Kingdom, Belgium, Russian Federation
Centocor Research & Development, Inc.

Completed

A Study of the Safety and Efficacy of Ustekinumab (CNTO 1275) in Patients With Moderate to Severe Psoriasis

Psoriasis

United States, United Kingdom, Germany, Canada, Austria, France, Switzerland
Centocor Research & Development, Inc.

Completed

A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus

Lupus Erythematosus, Systemic | Lupus Erythematosus, Cutaneous
VA Office of Research and Development
Oncovir, Inc.

Not yet recruiting

Harnessing Allo-immunity to Enhance Immune Checkpoint Inhibitor Responses in Advanced NSCLC (HAITEN-ICI)

Stage IV NSCLC

United States
Invirsa, Inc.
Biomedical Advanced Research and Development Authority

Recruiting

Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis

Acute Infectious Keratoconjunctivitis

United States, Thailand
Visterra, Inc.
Biomedical Advanced Research and Development Authority

Completed

Study of an Investigational Monoclonal Antibody, VIS410, in Subjects With Uncomplicated Influenza A

Influenza

United States, Estonia, South Africa, Bulgaria, Serbia, Ukraine, Latvia
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of Zika Vaccine mRNA-1893 in Healthy Flavivirus Seropositive and Seronegative Adults

Zika Virus

United States, Puerto Rico
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Safety, Tolerability, and Immunogenicity of mRNA-1325 in Healthy Adult Subjects

Zika Virus

United States
Rowan University
National Development and Research Institutes, Inc.

Completed

Incentives for Internet-based Adherence to SMBG for Teens With T1D

Contingent Versus Noncontingent Incentives
Achaogen, Inc.
Defense Medical Research and Development Program

Completed

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ACHN-975 in Healthy Volunteers

Healthy Volunteer

United States
VA Office of Research and Development
Analydata, Inc

Recruiting

Stellate Ganglion Block for PTSD (SGB-PTSD)

Post-traumatic Stress Disorder

United States
VA Office of Research and Development
Analydata, Inc

Completed

Acupuncture for PTSD (PTSD ACU)

Posttraumatic Stress Disorder

United States
Invirsa, Inc.
Biomedical Advanced Research and Development Authority

Completed

Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease

Dry Eye Disease

United States
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

Sublingual vs IV Atropine Bioavailability Study

Toxic Effect of Organophosphate and Carbamate Insecticides

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Completed

Dose-Confirmation Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1273 COVID-19 Vaccine in Adults Aged 18 Years and Older

SARS-CoV-2

United States
Genentech, Inc.
Biomedical Advanced Research and Development Authority

Completed

A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia (COVASTIL)

COVID-19 Pneumonia

United States, Spain, Brazil, Mexico
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

BARDA Securing Anthrax Immunity For the Elderly (B-SAFE)

Anthrax

United States
Biomedical Advanced Research and Development Authority
Rho, Inc.

Completed

Panblok H7 Vaccine Adjuvanted With AS03 or MF59

Influenza, Human

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Active, not recruiting

A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 (TeenCove)

SARS-CoV-2

United States, Dominican Republic
Cytovale, Inc.
Biomedical Advanced Research and Development Authority

Active, not recruiting

SQuISH-COVID: A Pilot Study

COVID-19 | Sepsis

United States
Altimmune, Inc.
Biomedical Advanced Research and Development Authority

Completed

NasoShield in Healthy Adults to Study Safety and Immunogenicity

Healthy Volunteers

United States
Roessingh Research and Development

Recruiting

Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis

Gait Analysis

Netherlands
Roessingh Research and Development

Recruiting

Soft-robotic Glove Support of High-demand Tasks

Neuromuscular Diseases | Sarcopenia

Netherlands
Roessingh Research and Development

Completed

Comfort Thresholds for Repetitive Forces

Healthy

Netherlands
Interactive Research and Development

Completed

Use of SMS and Interactive Reminders to Improve Timely Immunization Coverage

SMS | Immunization; Infection
Roessingh Research and Development

Recruiting

Influence of Hawthorne Effect and Dual-tasks on Gait in CP

Cerebral Palsy | Gait Disorders, Neurologic | Kinematics | Hawthorne Effect | Dual-tasks

Netherlands
Roessingh Research and Development

Completed

Validation IMU and EMG Algorithms in Stroke Patients

Stroke

Netherlands
Qpex Biopharma, Inc.
Shionogi Inc.; Biomedical Advanced Research and Development Authority

Not yet recruiting

PK & Safety Study of Xeruborbactam Oral Prodrug Combined With Ceftibuten in Participants With Renal Impairment

Bacterial Infections
Cipherome, Inc.
DHR Health Institute for Research and Development

Completed

Evaluating Pharmacogenomic Variants for Cardiology Therapeutics (CARES2)

Myocardial Infarction | Ischemic Stroke | Thrombosis | Bleeding | Stent Thrombosis

United States
Ethos Research & Development
Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

Completed

Evaluate the Use of the Foundation Pain Index and the Nutritional Supplement BioPlete™ in Adults With Chronic Pain

Chronic Pain

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

SAD/MAD Safety and PK Study of QPX9003 (Novel Polymyxin) in Normal Healthy Volunteers (QPX9003)

Bacterial Infections

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Drug-Drug Interaction Study of IV QPX2014 Combined With QPX7728 in Healthy Adult Subjects

Bacterial Infections

United States
AnGes, Inc.
Japan Agency for Medical Research and Development

Completed

Study of COVID-19 DNA Vaccine (AG0301-COVID19)

COVID-19

Japan
Kansas State University
National Development and Research Institutes, Inc.

Completed

Army Training at High Intensity Study (ATHIS)

Obesity

United States
Qpex Biopharma, Inc.
Shionogi Inc.; Biomedical Advanced Research and Development Authority

Recruiting

P1, DDI & MAD PK and Safety Study of Xeruborbactam Oral Prodrug in Combo With Ceftibuten in Healthy Participants

Bacterial Infections

Australia
Venatorx Pharmaceuticals, Inc.
Biomedical Advanced Research and Development Authority

Not yet recruiting

Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP (CERTAIN-2)

Hospital-acquired Pneumonia | Ventilator-associated Pneumonia
VA Office of Research and Development
ACADIA Pharmaceuticals Inc.

Recruiting

Pimavanserin for Insomnia in Veterans With PTSD (PIP-II)

Insomnia | Post-traumatic Stress Disorder

United States
AnGes, Inc.
Japan Agency for Medical Research and Development

Completed

Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)

COVID-19 Lower Respiratory Infection

Japan
AnGes, Inc.
Japan Agency for Medical Research and Development

Completed

Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)

COVID-19

Japan
University Hospital, Montpellier
National Development and Research Institutes, Inc.

Active, not recruiting

Measure of the Potential Evoked by Electric Stimulation (PE&CE)

Low Grade Glioma of Brain

France
Beckman Coulter, Inc.
Biomedical Advanced Research and Development Authority

Recruiting

Sepsis Clinical Decision Support [CDS] Master Enrollment Study Protocol

Severe Sepsis | Severe Sepsis Without Septic Shock

United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

Phase 1 Oral QPX7831 SAD and MAD in Healthy Adults

Bacterial Infections

Australia, United States
Qpex Biopharma, Inc.
Biomedical Advanced Research and Development Authority

Completed

P1 Single and Multiple Ascending Dose (SAD/MAD) Study of IV QPX7728 Alone and Combined With QPX2014 in NHV

Bacterial Infections

Australia, United States

Clinical Trials Sponsored by Intogrey Research and Development Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tunisia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations